Prescription drug · ANDA
CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) (Clindamycin palmitate hydrochloride) NDC 64980-511
Clindamycin palmitate hydrochloride 75 mg/5mL · Granule, For solution · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64980-511-10 | 6498005111064980051110 | 100 mL in 1 BOTTLE (64980-511-10)Marketed from Jun 12, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)Suffix: (Pediatric)
- Generic name (nonproprietary)
- clindamycin palmitate hydrochloride
- Active ingredients
- Clindamycin palmitate hydrochloride — 75 mg/5mL
- Dosage form
- Granule, For solution
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 64980
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201821
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
- Identifiers
- Product ID 64980-511_dbaca08e-0bce-412b-b46f-2a92bc597d8eSPL ID dbaca08e-0bce-412b-b46f-2a92bc597d8eSPL set ID 0800afad-e4cd-4f70-aaa1-a14547be4729RxCUI 562266UNII VN9A8JM7M7
- Pharmacologic class
- Lincosamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464980051110followed by a unit qualifier and the quantityPackage 64980-0511-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Clindamycin palmitate hydrochloride for oral solution, USP (Pediatric) (clindamycin palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the BOXED WARNING , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic…
Excerpt only. Read the full label for complete information.
About NDC 64980-511
- What is NDC 64980-511?
- 64980-511 is the product NDC for CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric), Clindamycin palmitate hydrochloride 75 mg/5mL granule, for solution, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) (Clindamycin palmitate hydrochloride).
- What is the active ingredient?
- Clindamycin palmitate hydrochloride.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)?
- 5 other product NDCs are listed under this name. See all CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Clindamycin Palmitate Hydrochloride (Pediatric)clindamycin palmitate hydrochloride | Clindamycin palmitate hydrochloride 75 mg/5mL | Powder, For solutionOral | Amneal Pharmaceuticals of New York LLC | 53746-468 | 53746-0468-19 |
| Clindamycin Palmitate Hydrochloride (Pediatric) | Clindamycin palmitate hydrochloride 75 mg/5mL | SolutionOral | NorthStar Rx LLC | 16714-483 | 16714-0483-0116714-0483-02 |
| Clindamycin Palmitate Hydrochloride (Pediatric) | Clindamycin palmitate hydrochloride 75 mg/5mL | SolutionOral | Aurobindo Pharma Limited | 65862-596 | 65862-0596-0165862-0596-02 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)clindamycin palmitate hydrochloride | Clindamycin palmitate hydrochloride 75 mg/5mL | Granule, For solutionOral | Bryant Ranch Prepack | 63629-2391 | 63629-2391-01 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)clindamycin palmitate hydrochloride | Clindamycin palmitate hydrochloride 75 mg/5mL | Granule, For solutionOral | Bryant Ranch Prepack | 72162-1809 | 72162-1809-01 |
Other NDCs under ANDA 201821
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)clindamycin palmitate hydrochloride | Clindamycin palmitate hydrochloride 75 mg/5mL | Granule, For solutionOral | Bryant Ranch Prepack | 63629-2391 |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric)clindamycin palmitate hydrochloride | Clindamycin palmitate hydrochloride 75 mg/5mL | Granule, For solutionOral | Bryant Ranch Prepack | 72162-1809 |